February 2026 saw robust M&A activity across the pharmaceutical and biotechnology sectors, marked by several high-value ...
Canada-based clinical-stage biotech Zymeworks ) and Royalty Pharma today announced an agreement for $250 million in funding ...
US pharma giant Pfizer has withdrawn its European application for a marketing authorization of Zumrad (sasanlimab) for the ...
Chinese biotech Innovent Biologics (HKEX: 01801) has secured approval from China’s National Medical Products Administration ...
Indian drugmaker Aurobindo Pharma plans to scale up production of Penicillin-G to more than 10,000 metric tonnes annually within the next 12 months. The Hyderabad-based pharmaceutical company ...
Chinese biotech Antengene (SEHK: 6996) has secured reimbursement in South Korea for Xpovio (selinexor) in combination with ...
Iranian biopharma CinnaGen has secured European marketing authorization for Zandoriah (teriparatide), a biosimilar to Forsteo ...
Sweden's pharmaceutical exports increased by more than 1% to 154 billion Swedish kroner in 2025. These new trade statistics ...
Progressive pulmonary fibrosis (PPF) represents one of the most challenging phenotypes within the interstitial lung disease ...
Novo Nordisk today announced an investment of 432 million euro ($510 million) in its facility in Monksland, Athlone, Ireland. This tabletting facility will provide significant additional manufacturing ...
The US Food and Drug Administration (FDA) accepted the New Drug Application (NDA) and granted Priority Review for rusfertide.
Denmark’s pharmaceutical industry association Lif has called on politicians to make patient access to new medicines and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results